The Key Ingredients to Commercializing a Medical Device Company

In this episode we announced our first sponsorship for Season 1, Mainstay Medical, and gave our thoughts on their therapy, Reactiv8. We discussed how Painteq president, Michael Enxing, got into the medical device industry and specifically the interventional pain space. He shared his advice to individuals that are just starting in the medical device industry. He discussed  why he and his companies choose to partner with ASPN. He gave a few pearls of wisdom on how to partner with industry. He shared the key ingredients on how to commercialize a medical device company. Finally, he discussed where he thinks Painteq and the  interventional pain space are headed.  Takeaways from the episode: Mainstay Medical is the first sponsor for Season 1 Michael Enxing shares his advice for newcomers in the medical device industry and for physician looking to partner with industry We discuss where we think Painteq and the interventional pain space is headed Host, Patrick Buchanan, MD: Dr. Buchanan is double board certified in Physical Medicine and Rehabilitation and Pain Medicine. His goal is to help his patients get their life back by managing their pain and focus on things they love and enjoy. https://www.californiapaindoctors.com/patrick-buchanan-m-d/ https://www.instagram.com/patdbmd/?hl=enHost, Timothy Deer, MD: Dr. Deer is the president and CEO of the Spine and Nerve Centers of the Virginias. Dr. Deer has led a revolution in interventional spine and nerve care by teaching thousands of physicians an algorithmic approach to care including methods that are less invasive at a lower risk for complications. https://centerforpainrelief.com/about/tim-deer-md/ https://twitter.com/doctdeer?lang=en https://www.instagram.com/timdeer30a/?hl=en Guest, Michael Enxing, President of Painteq Michael has been involved in the medical device industry for 3 decades. He has held several executive roles including the Global VP of Sales and Marketing for Nevro, CCO for Vertiflex, and CCO for Boston Scientific Neuromodulation Division. He has been a part of 4 acquisitions and mergers and 5 IPOs. He currently serves as the president of Painteq.   About ASPN: ASPN was created to bring the top minds in the fields of pain and neuroscience together. ASPN has a mission to improve education, highlight scientific curiosity, establish best practice, and elevate each other in a quest to improve the field of pain and neuroscience. All initiatives of ASPN are dedicated to improving patient outcomes, education, research, and innovation. ASPN's website and social links: https://aspnpain.com https://www.youtube.com/channel/UCixMNhEtOiRm1aQmDWtzxmg https://www.instagram.com/aspn_painneuro/ https://www.facebook.com/PainNeuro https://www.linkedin.com/in/aspn/ https://twitter.com/aspn_painneuro